UroGen Pharma Ltd. (URGN)

UroGen Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	92.9	171.99	95	55.41	44.36	52.86
Short-Term Investments	64.05	64.7	41.97	44.56	44.78	49.15
Cash & Short-Term Investments	156.95	236.69	136.97	99.96	89.14	102.02
Cash Growth	-34.89%	72.80%	37.02%	12.14%	-12.62%	-30.64%
Receivables	19.65	20.3	15.44	12.7	11.72	7.05
Inventory	7.13	9.23	5.67	4.33	4.83	1.96
Prepaid Expenses	12.06	8.85	10.28	11.1	7.48	3.36
Restricted Cash	1.08	1.08	0.82	0.81	1.23	1.23
Total Current Assets	196.87	276.14	169.19	128.91	114.39	115.62
Property, Plant & Equipment	6.24	3.79	2.36	3.75	3.15	4.2
Long-Term Investments	4.63	5.02	4.5	-	0.68	1.89
Other Long-Term Assets	0.98	0.77	2.26	2.96	1.53	0.29
Total Assets	208.72	285.71	178.31	135.62	119.75	122.01
Accounts Payable	13.56	10.93	6.51	5.53	5.79	3.27
Accrued Expenses	29.04	27.07	20.84	15.11	13.26	16.31
Current Portion of Leases	1.55	1.53	0.82	0.94	1.09	1.2
Other Current Liabilities	3.39	6.42	3.04	2.34	2.24	0.66
Total Current Liabilities	47.55	45.95	31.21	23.92	22.38	21.44
Long-Term Debt	122.51	121.73	98.55	97.54	-	-
Long-Term Leases	3.41	1.65	0.84	1.59	0.4	1.5
Other Long-Term Liabilities	128.62	125.18	112.92	101.94	88.56	2.72
Total Liabilities	302.09	294.51	243.52	224.98	111.33	25.65
Common Stock	0.13	0.12	0.09	0.06	0.06	0.06
Additional Paid-In Capital	806.5	797.25	614.04	487.79	475.7	452.53
Retained Earnings	-900.01	-806.22	-679.35	-577.1	-467.32	-356.5
Comprehensive Income & Other	0.01	0.06	0.01	-0.11	-0.03	0.27
Total Common Equity	-93.38	-8.8	-65.21	-89.36	8.41	96.36
Shareholders' Equity	-93.38	-8.8	-65.21	-89.36	8.41	96.36
Total Liabilities & Equity	208.72	285.71	178.31	135.62	119.75	122.01
Total Debt	127.47	124.92	100.21	100.06	1.49	2.7
Net Cash (Debt)	34.12	116.79	41.26	-0.1	88.33	101.21
Net Cash Growth	-76.02%	183.09%	-	-	-12.73%	-47.13%
Net Cash Per Share	0.72	2.72	1.43	-0.00	3.95	4.65
Filing Date Shares Outstanding	46.26	46.09	34.12	23.44	22.67	22.27
Total Common Shares Outstanding	46.2	42.23	32.49	23.13	22.46	22.17
Working Capital	149.32	230.19	137.97	104.99	92.01	94.18
Book Value Per Share	-2.02	-0.21	-2.01	-3.86	0.37	4.35
Tangible Book Value	-93.38	-8.8	-65.21	-89.36	8.41	96.36
Tangible Book Value Per Share	-2.02	-0.21	-2.01	-3.86	0.37	4.35
Machinery	4.5	4.31	4.02	3.83	3.58	2.83
Leasehold Improvements	0.63	0.63	0.62	0.62	0.62	0.61

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q